Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

• A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy
• IVIG vs SCIG in CIDP
• To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
• Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
• Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
• Proof-of-concept Study for BIVV020 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
• A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347
• Panzyga in CIDP Administered at Different Infusion Rates
• SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
• Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
• Subcutaneous Immunoglobulin for CIDP
• IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
• Transcriptome Analysis of the Peripheral Blood in CIDP
• IVIg for Demyelination in Diabetes Mellitus
• Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302
• Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
• Immunoglobulin Dosage and Administration Form in CIDP and MMN
• Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
• Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)
• Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
• Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg
• High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
• Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
• Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
• Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Study of CIDP Patients During IVIG Treatment
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
• Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)